Accuray Incorporated (ARAY)
NASDAQ: ARAY · IEX Real-Time Price · USD
1.800
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.810
+0.010 (0.56%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Accuray Revenue

Accuray had revenue of $430.55M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $101.13M. In the fiscal year ending June 30, 2023, Accuray had annual revenue of $447.61M with 4.12% growth.

Revenue (ttm)
$430.55M
Revenue Growth
-2.00%
P/S Ratio
0.41
Revenue / Employee
$420,463
Employees
1,024
Market Cap
178.64M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2023447.61M17.70M4.12%
Jun 30, 2022429.91M33.62M8.48%
Jun 30, 2021396.29M13.36M3.49%
Jun 30, 2020382.93M-35.86M-8.56%
Jun 30, 2019418.79M13.89M3.43%
Jun 30, 2018404.90M21.48M5.60%
Jun 30, 2017383.41M-15.39M-3.86%
Jun 30, 2016398.80M19.00M5.00%
Jun 30, 2015379.80M10.38M2.81%
Jun 30, 2014369.42M53.45M16.91%
Jun 30, 2013315.97M-93.25M-22.79%
Jun 30, 2012409.22M186.94M84.10%
Jun 30, 2011222.28M659.00K0.30%
Jun 30, 2010221.63M-11.97M-5.13%
Jun 30, 2009233.60M23.22M11.04%
Jun 30, 2008210.38M66.24M45.95%
Jun 30, 2007144.15M91.25M172.50%
Jun 30, 200652.90M23.27M78.53%
Jun 30, 200529.63M10.06M51.41%
Jun 30, 200419.57M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 226.63M
OptimizeRx 78.21M
Innate Pharma 68.49M
Metagenomi 47.26M
Fennec Pharmaceuticals 44.95M
MediWound 19.85M
Revenue Rankings